- Shock. // American Medical Association Family Medical Guide;2004, p579
The article provides information on shock, a physical condition in which blood flow throughout the body suddenly becomes inadequate or blocked. It deprives the tissues of the human body of having oxygen and other vital nutrients. Shock is usually caused by extremely low blood pressure, which...
- News in briefâ€¦. // PharmacoEconomics & Outcomes News;10/22/2005, Issue 389, p6
Presents news briefs on drug studies that have been published as of October 2005. Frequency of the use of corticosteroids for the treatment of infectious mononucleosis; Increase in the use of statins after a first acute myocardial infarction in Denmark; Association of inappropriate Î²-blocker...
- Physician Board Certification and the Care and Outcomes of Elderly Patients with Acute Myocardial Infarction. Chen, Jersey; Rathore, Saif S.; Yongfei Wang; Rodford, Martha J.; Krumholz, Harlan M. // JGIM: Journal of General Internal Medicine;Mar2006, Vol. 21 Issue 3, p238
BACKGROUND: Patients and purchasers prefer board-certified physicians, but whether these physicians provide better quality of care and outcomes for hospitalized patients is unclear. OBJECTIVE: We evaluated whether care by board-certified physicians after acute myocardial infarction (AMI) was...
- Beta--Blockers after Myocardial Infarction: Influence of First--Year Clinical Course on Long--Term Effectiveness. Viscoli, Catherine M.; Horwitz, Ralph I.; Singer, Burton H. // Annals of Internal Medicine;1/15/93, Vol. 118 Issue 2, p99
Presents a study that examined the influence of first year clinical course on the long-term effectiveness of the beta-blocker propranolol after myocardial infarction. Assessment of the mortality rates; Analysis of changes in the treatment of patients; Evaluation of the effectiveness of...
- Post-MI therapy: Low-dose beta blockers may be as good as, maybe better than, high-dose. // Geriatrics;Jun98, Vol. 53 Issue 6, p98
Presents a summary of the article `Beta-blocker dosages and mortality after myocardial infarction: Data from a large health maintenance organization,' by H.V. Barron, S. Viskin, R.J. Lundstrom and others, published in the March 9, 1998 issue of the `Archives of Internal Medicine' periodical.
- Should every survivor of a heat attack be given a beta-blocker? Hampton, J.R.; Breckenridge, A.; Rose, Geoffrey // British Medical Journal (Clinical Research Edition);7/3/1982, Vol. 285 Issue 6334, p33
Part I, II and III. Focuses on the use of a beta-blocker in survivor of heart attack in Great Britain. Difficulty to use beta-blockers in the initial stages of a heart attack; Reduction of mortality in patients treated with beta-blockers; Administration of beta-blockers in patients due to...
- Confidence in results of beta-blocker postinfarction trials. Baber, N.S.; Lewis, J.A. // British Medical Journal (Clinical Research Edition);6/12/1982, Vol. 284 Issue 6331, p1749
Examines the results of beta-blockers in myocardial infarctions. Reduction of mortality; Temporal distribution of trial admission; Improvements of technique for calculating confidence limits.
- Half of MI patients don't get beta blockers; those who don't get enough. // Modern Medicine;Sep95, Vol. 63 Issue 9, p38
Presents an abstract of the report `Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice,' by S. Viskin et. al. published on the May 1995 issue of `Journal of American College of Cardiology'.
- Percutaneous coronary intervention: cardiogenic shock. Ducas, John; Grech, Ever D // BMJ: British Medical Journal (International Edition);6/28/2003, Vol. 326 Issue 7404, p1450
Discusses cardiogenic shock. Progressive state of hypotension which leads to systematic hypoperfusion; Effects of cardiogenic chock; Management of cardiogenic shock.